Top View
- Drug/Substance Trade Name(S)
- Agonist-Antagonist Opioids: Theory and Clinical Practice Carl Rosow MD
- Controlled Substance Conversion Factors
- Properties of Opiate-Receptor Binding in Rat Brain (Naloxone/Opiate Antagonist)
- National Clearinghouse for Drug Abuse Information Selected Reference Series, Series 4, No
- Development of Diphenethylamines As Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
- United States Patent (19) 11 Patent Number: 4,692,451 Dodman Et Al
- Narcotics Dangerous Drugs
- Natural Products As a Source for Novel Analgesic Compounds
- Chemogenomics Knowledgebase and Systems Pharmacology for Hallucinogen Target Identification Salvinorin a As a Case Study
- Food and Drug Administration, HHS § 862.3650
- Tolerance, Antagonism and the Relation Between D-Lysergic Acid Diethylamide and Mescaline" (1958)
- Electrophysiological Interactions of Isomers of Cyclazocine with the Phencyclidine Antagonist Metaphit in Rat Cerebellar Purkinje Neurons
- Strategies for Developing Kappa Opioid Receptor Agonists for the Treatment of Pain with Fewer Side-Effects
- FDA Advisory Committee on the Most Appropriate Dose Or Doses of Naloxone to Reverse the Effects of Life-Threatening Opioid Overdose in the Community Settings
- Research Issues 26
- Pentazocine, Cyclazocine, and Nalorphine As Discriminative Stimuli
- United States Patent (19) 11 Patent Number: 5,866,164 Kuczynski Et Al
- Ed Domino's Early Studies of Psychoactive Drugs
- Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
- Torbugesic ® (Butorphanol Tartrate)
- Transdemal Delivery of Opioid Antagonist Prodrugs Audra L
- Critical Review of BUTORPHANOL
- Characterization of the Discriminative Stimulus Effects of Nitrous Oxide
- Nalorphine Hydrochloride (BANM, Rinnm) Ceptors Modulate Itch, an Opioid Antagonist Might Be Useful in Nausea and Vomiting Have Occurred with Naloxone
- Investigations of Salvinorin A: Synthetic Isolation, Quantification, and in Vivo Characteristics
- Drugs of Abuse, a DEA Resource Guide (2020 Edition)
- United States Patent (19) 11 Patent Number: 6,007,841 Caruso (45) Date of Patent: Dec
- Method of Administering Narcotic Antagonists and Analgesics and Novel Dosage Forms Containing Same Anwar A
- Opioid A4: Antidotes in Depth
- Prescribing and Over-The-Counter Drugs
- Food and Drug Administration, HHS § 862.3660
- Dextromethorphan Elisa Kit Instructions Product #131419 & 131415 (Rtu) Forensic Use Only
- The Effect of Analgesic Drugs on the Release of Acetylcholine from Electrically Stimulated Guinea-Pig Ileum
- Pharmacological Aspects of Over-The-Counter Opioid Drugs Misuse
- Salvinorin A: Fragment Synthesis and Modeling Studies
- Drugs of Abuse (2017 Edition)
- Kinetic Parameters of Narcotic Agonists and Antagonists, with Particular Reference to N-Allylnoroxymorphone (Naloxone) by H
- Alphaprodine in Twenty Years of Sedation Experience Dr
- Pcp) Elisa Kit Instructions Product # 130519 & 130515 (Rtu) Forensic Use Only
- Policies and Procedures for Using Controlled Substances in Research